Smiths Group PLC
13 November 2001
SMITHS GROUP ANNUAL GENERAL MEETING,
CHAIRMAN'S STATEMENT
Speaking at the AGM held at 12:00 noon today at 10 Aldermanbury, London EC2,
Keith Orrell-Jones, Chairman of Smiths Group said:
'We announced our preliminary results only two weeks after September 11 during
a time of great economic uncertainty. Now, two months after those events, some
of the effects have become more evident. But there remains a lack of clear
visibility about the future.
'Our experience has been that, in addition to the well-publicised consequences
for the aerospace sector, the last eight weeks have seen a noticeable
reduction in orders for a wide range of other products and services. This has
been felt by parts of our Industrial and Sealing businesses, some of which
have seen a 15% fall in orders on a year-on-year basis for that period.
'We indicated at the preliminary results meeting that the slowdown in civil
aerospace would be sharper and deeper as a consequence of September 11. The
aircraft manufacturers have kept us closely informed of their planned build
rates, but uncertainty will persist until airline revenues and profitability
regain some stability. As stated in the results presentation, our civil
aerospace sales, representing less than 20% of group sales, will progressively
decline through the current financial period and could drop by up to 40% in a
full year.
'The company took a £72m exceptional charge in July 2001 for merger-related
reorganisations now underway in Aerospace and Sealing Solutions. These involve
a net reduction of 1,600 jobs and the transfer of 500 jobs from the US and the
UK to lower cost countries. These and other predicted savings are on target.
Following the recent changes to the business outlook, we shall be further
downsizing, mainly in Aerospace, and an exceptional charge in the range of £40
- 50m will be incurred in the current year.
'Based on current expectations, we expect that the factors referred to above
will result in first half operating profits in our continuing businesses
showing a year-on-year decline of approximately 15 per cent. It is early days
to comment on the outlook for the full year. But we do not expect to recover
fully in the second half from the first half shortfall.
'However, the company's medical, defence and detection/protection businesses
will continue to perform strongly in the present environment, and the
restructuring measures we are taking are already having a significant impact
on the cost base, the benefit from which will increase as the year
progresses.'
-ends-
Press enquiries to:
Russell Plumley
Tel: 020 8457 8203
Mobile: 07801 040 720
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.